Medindia

X

Platinum-Based Chemotherapy Drug Has Significantly Increased Survival Rates in Testicular Cancer

by Kathy Jones on  July 30, 2013 at 9:40 PM Cancer News   - G J E 4
A new study testing the effectiveness of a platinum-based chemotherapy drug in treating testicular cancer reveals that the survival rate in British men suffering from the condition increased by 96 percent.
 Platinum-Based Chemotherapy Drug Has Significantly Increased Survival Rates in Testicular Cancer
Platinum-Based Chemotherapy Drug Has Significantly Increased Survival Rates in Testicular Cancer
Advertisement

Figures compiled by Cancer Research UK show that 96 percent men have successfully been treated for testicular cancer, which is a big improvement since the 1970s when the survival rate was lower than 70 percent, the Independent reported.

Advertisement
Cisplatin had first been identified as a compound in the 19th century but researchers did not realise its application in oncology until the late 1970s.

Despite its side-effects, ranging from numbness in fingers and toes to tinnitus and hearing loss, the compound is one of the most commonly-used cancer drugs.

Source: ANI
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All